(2E)-1-(4-bromophenyl)-3-(2-chloro-6-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

N-(4-Fluorobenzyl)-2-((R)-5-(3-methylureido)-2',4'-dioxo-2,3-dihydrospiro[indene-1,5'-oxazolidin]-3'-yl)-N-((S)-1,1,1-trifluoropropan-2-yl)acetamide, 97.0%, 10mg

Dibromoformaldoxime, 96.0%, 1g

N-benzyl-1-phenylethan-1-amine, 98%, 5g

1-(2-Ethoxy-phenyl)-pyrimidine-2,4,6-trione, 95.0%, 500mg

(2-Bromo-4-chloropyridin-3-yl)methanol, 1g

Ethyl 2-amino-5-methylbenzoate, 95.0%, 25g

7-(tert-Butoxy)-7-oxoheptanoic acid, 98%, 5g

Colonna capillare per GC ROTI®Cap-1701 MS, 60 m, 0.32 mm, 0.50 µm, 1 Pezzo(i)

Methyl 6-chloro-5-fluoropyrazine-2-carboxylate, 97%, 250mg

Ethyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-2-carboxylate, 95.0%, 250mg

(2E)-3-(2-METHYLPHENYL)-2-PROPENOIC ACID, METHYL ESTER, 95.0%, 250mg

1-(2-(4-Methylpiperazin-1-yl)ethyl)-1h-pyrazol-4-amine, 98%, 5g